Literature DB >> 16140471

Isolation and characterization of bacteriophages of the Burkholderia cepacia complex.

Kimberley D Seed1, Jonathan J Dennis.   

Abstract

The Burkholderia cepacia complex consists of nine phenotypically similar but genotypically distinct beta-proteobacteria that are metabolically diverse and highly antibiotic resistant. Because of this exceptional intrinsic antibiotic resistance, infections with B. cepacia complex members are difficult to treat clinically and new alternative therapies are required. One strategy that holds some promise is the use of naturally occurring antibacterial bacteriophages that could potentially bind to and lyse B. cepacia complex cells in vivo. Towards that end, we used enrichment techniques to isolate lytic and lysogenic bacteriophages specific to the B. cepacia complex. The newly isolated bacteriophages were characterized by host range analysis, electron microscopy, genome restriction analysis, and partial DNA sequencing. These isolates include a bacteriophage with one of the broadest host ranges yet identified for any bacteriophage specific to the B. cepacia complex, and the first description of bacteriophages capable of lysing B. ambifaria.

Entities:  

Mesh:

Year:  2005        PMID: 16140471     DOI: 10.1016/j.femsle.2005.08.011

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  23 in total

Review 1.  Role of phages in the pathogenesis of Burkholderia, or 'Where are the toxin genes in Burkholderia phages?'.

Authors:  Elizabeth J Summer; Jason J Gill; Chris Upton; Carlos F Gonzalez; Ry Young
Journal:  Curr Opin Microbiol       Date:  2007-08-23       Impact factor: 7.934

2.  Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.

Authors:  Kimberley D Seed; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

3.  Statistical structure of host-phage interactions.

Authors:  Cesar O Flores; Justin R Meyer; Sergi Valverde; Lauren Farr; Joshua S Weitz
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

4.  Identification of potential diagnostic markers among Burkholderia cenocepacia and B. multivorans supernatants.

Authors:  Tiffany Mott; Michael Soler; Sierrah Grigsby; Ronald Medley; Gregory C Whitlock
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Occurrence of Vibrio parahaemolyticus and its specific phages from shrimp ponds in east coast of India.

Authors:  K M Alagappan; B Deivasigamani; S T Somasundaram; S Kumaran
Journal:  Curr Microbiol       Date:  2010-02-07       Impact factor: 2.188

6.  Genomes and characterization of phages Bcep22 and BcepIL02, founders of a novel phage type in Burkholderia cenocepacia.

Authors:  Jason J Gill; Elizabeth J Summer; William K Russell; Stephanie M Cologna; Thomas M Carlile; Alicia C Fuller; Kate Kitsopoulos; Leslie M Mebane; Brandi N Parkinson; David Sullivan; Lisa A Carmody; Carlos F Gonzalez; John J LiPuma; Ry Young
Journal:  J Bacteriol       Date:  2011-07-29       Impact factor: 3.490

7.  Aerosol phage therapy efficacy in Burkholderia cepacia complex respiratory infections.

Authors:  Diana D Semler; Amanda D Goudie; Warren H Finlay; Jonathan J Dennis
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

8.  Inactivation of Burkholderia cepacia complex phage KS9 gp41 identifies the phage repressor and generates lytic virions.

Authors:  Karlene H Lynch; Kimberley D Seed; Paul Stothard; Jonathan J Dennis
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

9.  Genomic characterization of Ralstonia solanacearum phage phiRSA1 and its related prophage (phiRSX) in strain GMI1000.

Authors:  Akiko Fujiwara; Takeru Kawasaki; Shoji Usami; Makoto Fujie; Takashi Yamada
Journal:  J Bacteriol       Date:  2007-10-26       Impact factor: 3.490

10.  Production of highly stable spray dried phage formulations for treatment of Pseudomonas aeruginosa lung infection.

Authors:  Rachel Y Chang; Jennifer Wong; Ash Mathai; Sandra Morales; Elizabeth Kutter; Warwick Britton; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2017-09-07       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.